BioCentury
ARTICLE | Clinical News

RQ-00000004: Phase II started

May 13, 2013 7:00 AM UTC

RaQualia said that CJ Group's CJ CheilJedang Co. affiliate began a Korean Phase II trial of RQ-00000004. The trial start triggered an undisclosed milestone payment to RaQualia under a 2010 deal granti...